Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0017 | 0.0699 | 0.6617 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0016 | 0.061 | 0.0452 |
Loa Loa (eye worm) | troponin T | 0.0063 | 0.2993 | 0.2876 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Plasmodium vivax | acetyl-CoA synthetase, putative | 0.0007 | 0.0165 | 0.2359 |
Brugia malayi | Troponin I | 0.0106 | 0.517 | 0.5089 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0699 | 0.0543 |
Leishmania major | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0165 | 0.0362 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0017 | 0.0699 | 1 |
Mycobacterium tuberculosis | Peptide synthetase MbtE (peptide synthase) | 0.0007 | 0.0165 | 0.0546 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0094 | 0.4552 | 0.6973 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0094 | 0.4552 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0651 | 0.6071 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.061 | 0.0547 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0007 | 0.0165 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.517 | 0.5089 |
Brugia malayi | hypothetical protein | 0.0063 | 0.2993 | 0.2876 |
Brugia malayi | Troponin T | 0.0063 | 0.2993 | 0.2876 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0016 | 0.061 | 0.0452 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD1 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0165 | 0.0546 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0046 | 0.2162 | 0.4552 |
Trypanosoma brucei | polo-like protein kinase | 0.0094 | 0.4552 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0996 | 0.0845 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1527 | 0.1385 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0007 | 0.0165 | 0.0362 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0996 | 1 |
Onchocerca volvulus | Troponin I homolog | 0.0106 | 0.517 | 0.7955 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0165 | 0.0362 |
Toxoplasma gondii | AMP-binding enzyme domain-containing protein | 0.0007 | 0.0165 | 0.5 |
Trypanosoma brucei | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0165 | 0.0362 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0996 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0202 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.1527 | 0.1385 |
Mycobacterium tuberculosis | Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase | 0.0007 | 0.0165 | 0.0546 |
Echinococcus multilocularis | GPCR, family 2 | 0.0016 | 0.061 | 0.0547 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0046 | 0.2162 | 0.4552 |
Onchocerca volvulus | Troponin T, skeletal muscle homolog | 0.0132 | 0.6456 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0996 | 0.0845 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0094 | 0.4552 | 0.4461 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0996 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.1527 | 0.2164 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0699 | 0.0543 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0094 | 0.4552 | 0.4461 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0996 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.061 | 0.0707 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0651 | 0.6071 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0996 | 1 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0007 | 0.0165 | 0.0362 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0996 | 0.2189 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0094 | 0.4552 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0168 | 0.8293 | 1 |
Leishmania major | acetyl-CoA synthetase, putative | 0.0007 | 0.0165 | 0.0362 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0996 | 1 |
Schistosoma mansoni | troponin t invertebrate | 0.0132 | 0.6456 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0996 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.2317 | 0.2188 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0094 | 0.4552 | 0.6973 |
Toxoplasma gondii | propionate-CoA ligase | 0.0007 | 0.0165 | 0.5 |
Leishmania major | acetyl-CoA synthetase, putative | 0.0007 | 0.0165 | 0.0362 |
Echinococcus granulosus | oncosphere protein Tso22e | 0.0132 | 0.6456 | 0.7741 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0996 | 0.2189 |
Loa Loa (eye worm) | troponin I | 0.0106 | 0.517 | 0.5089 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0996 | 0.1895 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0699 | 0.0543 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0017 | 0.0699 | 0.6421 |
Mycobacterium tuberculosis | P-hydroxybenzoyl-AMP ligase FadD22 | 0.0007 | 0.0165 | 0.0546 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Onchocerca volvulus | Troponin T, skeletal muscle homolog | 0.0063 | 0.2993 | 0.4495 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0996 | 0.0845 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0023 | 0.0996 | 0.1895 |
Brugia malayi | Troponin T | 0.0063 | 0.2993 | 0.2876 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0016 | 0.061 | 0.0547 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0165 | 0.0362 |
Echinococcus multilocularis | oncosphere protein tso22e oncosphere protein tso22d oncosphere protein tso22c oncosphere protein tso22b oncosphere protein tso22 | 0.0132 | 0.6456 | 0.7741 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0699 | 0.0543 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.061 | 0.0707 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0996 | 1 |
Mycobacterium tuberculosis | Fatty-acid-CoA synthetase FadD17 (fatty-acid-CoA synthase) (fatty-acid-CoA ligase) | 0.0007 | 0.0165 | 0.0546 |
Mycobacterium tuberculosis | Peptide synthetase MbtF (peptide synthase) | 0.0007 | 0.0165 | 0.0546 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.061 | 0.0707 |
Brugia malayi | Troponin family protein | 0.0106 | 0.517 | 0.5089 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.2993 | 0.2876 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.061 | 0.0707 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0094 | 0.4552 | 0.5398 |
Brugia malayi | Troponin T | 0.0063 | 0.2993 | 0.2876 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0996 | 0.0845 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0996 | 0.0845 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0699 | 0.0543 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0996 | 0.1895 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0168 | 0.8293 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.2317 | 0.2188 |
Mycobacterium tuberculosis | Probable medium chain fatty-acid-CoA ligase FadD14 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0165 | 0.0546 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0996 | 0.2189 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0996 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0651 | 0.6071 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.061 | 0.0547 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0996 | 1 |
Schistosoma mansoni | troponin I | 0.0106 | 0.517 | 0.7955 |
Schistosoma mansoni | hypothetical protein | 0.0106 | 0.517 | 0.7955 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0017 | 0.0699 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Schistosoma mansoni | kinase | 0.0048 | 0.2225 | 0.3274 |
Giardia lamblia | Kinase, PLK | 0.0094 | 0.4552 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0094 | 0.4552 | 1 |
Loa Loa (eye worm) | troponin | 0.0063 | 0.2993 | 0.2876 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0094 | 0.4552 | 1 |
Schistosoma mansoni | troponin I | 0.0106 | 0.517 | 0.7955 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.517 | 0.5089 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0996 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0016 | 0.061 | 0.0452 |
Mycobacterium tuberculosis | Probable peptide synthetase Nrp (peptide synthase) | 0.0007 | 0.0165 | 0.0546 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0996 | 1 |
Toxoplasma gondii | Acetyl-coenzyme A synthetase 2, putative | 0.0007 | 0.0165 | 0.5 |
Trypanosoma brucei | acetyl-CoA synthetase, putative | 0.0007 | 0.0165 | 0.0362 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD8 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0165 | 0.0546 |
Schistosoma mansoni | troponin I | 0.0106 | 0.517 | 0.7955 |
Schistosoma mansoni | troponin I | 0.0106 | 0.517 | 0.7955 |
Onchocerca volvulus | 0.0023 | 0.0996 | 0.1321 | |
Echinococcus granulosus | troponin i | 0.0106 | 0.517 | 0.6158 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.061 | 0.0452 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD10 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0165 | 0.0546 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0996 | 0.0845 |
Echinococcus multilocularis | troponin i | 0.0106 | 0.517 | 0.6158 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0651 | 0.6071 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0094 | 0.4552 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0.0699 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0094 | 0.4552 | 0.5398 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 1.65 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 1.91 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 2.27 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 3 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 9 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 84 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 3.67 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = -1 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 3 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 9 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 84 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 5.84 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 1.42899 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.